ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1335

Factors Associated with Progressive Radiographic Damage in Gout: A Prospective Observational Study

Alastair Eason1, Meaghan House2, Zoe Vincent1, Julie Knight1, Paul Tan1, Anne Horne2, Gregory Gamble2, Anthony Doyle1, William J. Taylor3 and Nicola Dalbeth2, 1University of Auckland, Auckland, New Zealand, 2Department of Medicine, University of Auckland, Auckland, New Zealand, 3Department of Medicine, University of Otago Wellington, Wellington, New Zealand

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Imaging of Rheumatic Diseases Poster II: X-ray, MRI, PET and CT

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Radiographic damage is frequently observed in patients with longstanding
gout.  Although cross-sectional studies have described factors associated with
joint damage in gout, there are very few prospective studies that have
investigated radiographic progression.  The aim of this prospective
observational study was to determine the rate of progression and factors
associated with progressive radiographic damage in gout.

 

Methods: People
with gout according to the 1977 ARA criteria, with disease duration <10
years were recruited into this prospective observational study.  At the
baseline visit, detailed clinical assessment was undertaken in 295 participants
including subcutaneous tophus count, joint counts, blood tests and plain
radiographs of the hands and feet.  Participants were invited to attend a
further study visit with repeat testing three years after the baseline visit.   Paired
radiographs (XR) were scored for erosion and joint space narrowing (JSN) in
chronological order by two readers according to the gout-modified Sharp van der
Heijde XR damage score.  Both readers were blinded to each other’s scores and
all clinical variables.  Inter-reader intraclass correlation coefficient (95%
CI) for the XR damage score was 0.91 (0.87-0.94).  The mean scores for both
readers were used in the analysis.  Pearson correlation and stepwise linear
regression models were used to identify variables independently associated with
progressive XR damage. 

 

Results: Paired
XR were available for 135 participants.  At baseline, mean (SD) erosion score
was 4.9 (10.2), JSN score was 6.0 (8.6) and total XR damage score was 10.9
(16.9).  At Year 3, mean (SD) erosion score was 7.7 (14.6), JSN score was 7.1
(9.7) and total XR damage score was 12.8 (19.2).  Change in subcutaneous tophus
count correlated with change in erosion score (r=0.36, p<0.001), change in
JSN score (r=0.33, p=0.001), and change in total XR damage score (r=0.53,
p<0.001). In stepwise linear regression analysis, baseline XR damage score and
change in subcutaneous tophus count independently predicted change in total XR damage
score over three years (model R2=0.48, p<0.001), with the
following baseline variables excluded from the model: tophus count, swollen
joint count, tender joint count, C-reactive protein, and serum urate.  Baseline
XR score and change in subcutaneous tophus count also predicted change in the XR
erosion and JSN scores when analysed as separate dependent variables in the
regression models.

 

Conclusion : The
presence of radiographic damage at baseline and development of new subcutaneous
tophi are associated with progressive joint damage in people with gout.  These
data provide further evidence that the tophus plays a central role in joint
damage in gout.


Disclosure: A. Eason, None; M. House, None; Z. Vincent, None; J. Knight, None; P. Tan, None; A. Horne, None; G. Gamble, None; A. Doyle, None; W. J. Taylor, None; N. Dalbeth, Takeda, AstraZeneca, Pfizer, 5,AstraZeneca, 8,Ardea Biosciences, 2.

To cite this abstract in AMA style:

Eason A, House M, Vincent Z, Knight J, Tan P, Horne A, Gamble G, Doyle A, Taylor WJ, Dalbeth N. Factors Associated with Progressive Radiographic Damage in Gout: A Prospective Observational Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/factors-associated-with-progressive-radiographic-damage-in-gout-a-prospective-observational-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-associated-with-progressive-radiographic-damage-in-gout-a-prospective-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology